New approaches to filling the gap in tuberculosis drug discovery
2007
New Approaches to Tuberculosis Drug Discovery
publication
Evidence: low
Author Information
Author(s): Martina Casenghi, Stewart T. Cole, Carl F. Nathan
Primary Institution: Médecins Sans Frontières
Hypothesis
How can we improve drug discovery for tuberculosis given the current challenges?
Conclusion
Despite the existence of a tuberculosis drug pipeline, there are still too few candidates to effectively combat the disease.
Supporting Evidence
- There is a tuberculosis drug pipeline for the first time in decades.
- Only three new drugs for tuberculosis were developed between 1975 and 2004.
- Funding for tuberculosis research is alarmingly inadequate compared to other diseases.
Takeaway
Scientists are trying to find new medicines for tuberculosis, but there aren't enough options available to help people who are sick.
Limitations
Current funding for tuberculosis research is inadequate, and there is a lack of access to necessary expertise and resources.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website